Career history of Neil J. Sandler
Former positions of Neil J. Sandler
| Companies | Position | Start | End |
|---|---|---|---|
Symphony Capital LLC
 Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York. | Private Equity Investor | 01/01/2002 | 31/12/2007 |
Symphony Genisis, Inc.
 Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Director/Board Member | - | - |
Symphony Allegro, Inc.
 Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Director/Board Member | - | - |
Statistics
International
| United States | 4 |
Operational
| Director/Board Member | 2 |
| Private Equity Investor | 1 |
Sectoral
| Health Technology | 3 |
| Finance | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Private companies | 3 |
|---|---|
Symphony Capital LLC
Symphony Capital LLC Investment ManagersFinance Symphony Capital LLC (Symphony Capital) is a private equity firm founded in 2002. The firm is headquartered in New York. | Finance |
Symphony Allegro, Inc.
Symphony Allegro, Inc. Pharmaceuticals: MajorHealth Technology Symphony Allegro, Inc. manufactures biopharmaceutical drugs. It develops clinical trials for the treatment of schizophrenia, bipolar, migraine, and panic attack disorders. The company was founded in 2006 and is headquartered in Rockville, MD. | Health Technology |
Symphony Genisis, Inc.
Symphony Genisis, Inc. Pharmaceuticals: MajorHealth Technology Symphony GenIsis, Inc. manufactures biopharmaceutical drugs. It develops and researches on cholesterol-lowering drug, ISIS 301012 and two novel diabetes drugs from its metabolic diseases program. The company is located in Rockville, MD | Health Technology |
- Stock Market
- Insiders
- Neil J. Sandler
- Experience
